Pharmacy

Home Pharmacy

Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common

About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects

ATA Issues Guidelines for Managing Anaplastic Thyroid Cancer

Evidence-based guidelines address diagnosis, evaluation, and treatment, including early multidisciplinary care team involvement

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Senators Urge Biden to Waive Rules That Restrict COVID-19 Vaccine Production

Waiver could open the door for generic or other manufacturers to make more vaccines

Europe Surpasses 1 Million COVID-19 Deaths

WHO wants to emphasize the need for Europe to maintain social distancing and speed up vaccinations

U.S. Overdose Deaths Have Soared During COVID-19 Pandemic

Increase largely driven by illicitly manufactured fentanyl and other synthetic opioids

Thousands of Vaccinated People in U.S. Infected With COVID-19

New data are the first to indicate how effective COVID-19 vaccines are in real life

CDC Panel Says It Needs More Time to Study J&J Vaccine Clotting Cases

Advisers to the CDC say they do not have enough information or time to recommend how to proceed and they will meet again within 10 days

Psilocybin Compared With Escitalopram for Depression

No difference seen in change in depression scores at six weeks for psilocybin plus placebo versus psilocybin plus escitalopram

AAN: Race May Affect Response to Anti-CD20 Therapy for MS, NMOSD

B-cell repopulation occurs more often in African American versus White patients between six and 12 months after anti-CD20 infusion